BioSpace News Archive

Policy

BriaCell Files Patent Application for Novel Immune Therapies for Multiple Disease Indications

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO).

May 20, 2020
·
4 min read
BioCapital

BIOQUAL Announces Release of Two COVID-19 Research Publications

BIOQUAL announces the release of two research publications in Science Magazine of our non-human primate model development efforts and our first successful testing of a COVID-19 vaccine candidate

May 20, 2020
·
1 min read
BioForest

SOLIUS Releases White Paper Exploring Potential Impact of Vitamin D On COVID-19

SOLIUS is a biotechnology company that aims to improve health for people affected by conditions scientifically correlated with a reduction in sun exposure and vitamin D deficiency.

May 20, 2020
·
2 min read
BioCapital

Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab

Incyte (NASDAQ:INCY) and MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) today announced the validation of the European Marketing Authorization Application (MAA) for tafasitamab, an anti-CD19 antibody.

May 20, 2020
·
10 min read
Pharm Country

Olympus Hosts Two Live Webinars on COVID-19 Resources and Information for Olympus Customers

Olympus is hosting two live webinars, May 21-22, to address the specific concerns raised by customers during the SARS-CoV2 pandemic.

May 20, 2020
·
2 min read